Pharmaceutical Industry on Pace for Record Lobbying Spending
Pfizer, Merck, Eli Lilly and other drug giants are spending record amounts on lobbying as they fight the Trump administration on vaccine policies and more.
12 posts with this tag
Big Pharma
Sanders and King Unveil First-Ever Bill to Ban All Prescription Drug Ads
The bill follows repeated calls by RFK Jr. and others in the MAHA orbit to ban direct-to-consumer pharmaceutical advertising.
Top Pharma Cash Recipient Takes Key Industry Oversight Job
The pharmaceutical industry has a chance to call the shots as it works to undermine drug pricing negotiations with its favorite, Kentucky Republican Brett Guthrie, heading the Energy and Commerce Committee.
PhRMA Showers Millions on Dark Money Groups Fighting Drug Price Reforms
We run down the recipients of drugmaker donations revealed in PhRMA's latest tax filing.
PhRMA Funnels Millions to Groups Fighting Drug Pricing Reforms
The pharma lobby gave more than $16 million in 2022 to advocacy groups, many of them ostensibly “grassroots,” that are battling the Medicare drug price negotiations now underway.
Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
Corporate Dems’ Rapidly Growing ‘Dark Money’ Arm
Tax documents reveal the group Center Forward received a record $18.8 million in 2021 and spent big to back conservative Democrats who bucked their party on drug pricing reforms.
News Outlet Founded by Blue Dog Dem Operatives Promotes Big Pharma's Lobbying Aims
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money
On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.